V
Vaxart
South San Francisco, United States
Founded 2004 NASDAQ: VXRT
About
Oral vaccine platform using recombinant vectors and nanoparticle technology
Company Details
- Type
- public
- Employees
- 100+
- Funding
- Public
Key Products
- VAAST Platform
- VXA Tablets